Meet NanoString Scientists at the AMP 2019 Annual Meeting & Expo
When Elaine Lyon, Ph.D., a scientist on the board of the Association for Molecular Pathology (AMP) was asked why she is involved with AMP, its activities and initiatives, she quoted the famous Captain James T. Kirk from Star Trek and...
The challenges of profiling miRNA Biomarkers from FFPE and Biofluid Samples
In 1993, Dr. Victor Ambros’ lab discovered a small RNA sequence, Lin-4, that was “essential for the normal temporal control of diverse postembryonic developmental events in C. elegans”. Sequence analysis revealed that the molecule was 22 nucleotides long and didn’t...
The bench side of organ transplant: Challenges and solutions
“It is infinitely better to transplant a heart than bury it to be devoured by worms,” said Dr. Christiaan Barnard, the father of the heart transplant. It’s hard to disagree with this statement! Organ transplant today is an established treatment...
A day (or two) with the Experts: the 2019 EU NanoString Summits Crosstalk
Since 2017 NanoString has hosted day-long summits in some of the liveliest and most charming European locations, where scientists and key opinion leaders have had the opportunity to share with their peers how NanoString Technologies has facilitated their breakthroughs, from...
Aiming at the Achilles’ heel of cancer: multiplexed lung cancer fusion detection without FISH or NGS
Lung cancer is the most commonly diagnosed cancer worldwide, and the leading cause of cancer deaths in the United States. It is generally divided into two types, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), based on...